Kalera Public Ltd Co: Nasdaq/NYSE listing notice — Kalera receives Nasdaq delisting notice for bid price deficiency; requests hearing

Kalera Public Ltd Co

Nasdaq Staff determined to delist Kalera's ordinary shares and warrants based on closing bid price below $1 for 30 consecutive days and below $0.10 for 10 consecutive days.
Company received the delisting notice on November 21, 2022, and has requested a hearing before the Nasdaq Hearings Panel to stay suspension and delisting.
There are no assurances that a stay will be granted or that a favorable decision will be obtained.
Kalera's ordinary shares trade under symbol KAL and warrants under KALWW on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Kalera Public Ltd Co received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(3)(A)(iii)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(3)(A)(iii)

Exact text from the filing

November 21, 2022, Kalera Public Limited Company (the “Company”) received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined to delist the Company’s securities unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Staff’s determination was based upon the Company evidencing a closing bid price of less than $1 per share for the preceding thirty consecutive trading days, in contravention of Nasdaq Listing Rule 5550(a)(2), and less than $0.10 per share for the prece

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-22-033399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.